32078939|t|Cholinesterases, alpha-glycosidase, and carbonic anhydrase inhibition properties of 1H-pyrazolo[1,2-b]phthalazine-5,10-dione derivatives: Synthetic analogues for the treatment of Alzheimer's disease and diabetes mellitus.
32078939|a|In this study, using the Cu(OTf)2 catalyst, 1H-pyrazolo[1,2-b]phthalazine-5,10-dione derivative molecules were carried out in one step and with high yield (86-91%). The previously synthesized 1H-pyrazolo[1,2-b]phthalazine-5,10-dione derivatives, carbonic anhydrase I and II isozymes (hCA I and II), acetylcholinesterase (AChE), butyrylcholinesterase (BChE) and alpha-glycosidase (alpha-Gly) enzymes with Ki values in the range of 4.88-15.94 nM for hCA I, 7.04-20.83 nM for hCA II, 68.25-158.27 for AChE, 60.17-91.27 for BChE and 0.36-2.36 nM for alpha-Gly, respectively. In silico studies were performed on the molecules inhibiting hCA I, hCA II, AChE, BChE and alpha-Gly receptors. When we evaluated the data obtained in this work, we determined the inhibition type of the 1H-pyrazolo[1,2-b]phthalazine-5,10-dione derivatives at the receptors. Reference inhibitors were used for all enzymes.
32078939	84	124	1H-pyrazolo[1,2-b]phthalazine-5,10-dione	Chemical	-
32078939	179	198	Alzheimer's disease	Disease	MESH:D000544
32078939	203	220	diabetes mellitus	Disease	MESH:D003920
32078939	247	255	Cu(OTf)2	Chemical	MESH:C012077
32078939	266	306	1H-pyrazolo[1,2-b]phthalazine-5,10-dione	Chemical	-
32078939	414	454	1H-pyrazolo[1,2-b]phthalazine-5,10-dione	Chemical	-
32078939	468	495	carbonic anhydrase I and II	Gene	759;760
32078939	506	518	hCA I and II	Gene	1591
32078939	521	541	acetylcholinesterase	Gene	43
32078939	543	547	AChE	Gene	43
32078939	550	571	butyrylcholinesterase	Gene	590
32078939	573	577	BChE	Gene	590
32078939	670	675	hCA I	Gene	1591
32078939	720	724	AChE	Gene	43
32078939	742	746	BChE	Gene	590
32078939	854	859	hCA I	Gene	1591
32078939	869	873	AChE	Gene	43
32078939	875	879	BChE	Gene	590
32078939	996	1036	1H-pyrazolo[1,2-b]phthalazine-5,10-dione	Chemical	-

